Company Insights

ZCMD supplier relationships

Explore interactive graphBrowse insights index
ZCMD supplier relationship map

Zhongchao Inc (ZCMD): supplier relationships, capital-market links, and what investors should price in

Zhongchao Inc operates as a China-based healthcare information, education and training services provider, monetizing primarily through paid training, information services and related professional offerings to medical institutions and practitioners. The public company structure and recent capital-market activity indicate a revenue-driven operating model with margin pressure and negative earnings, while discrete relationships with underwriters, market venues, and investor-relations contacts shape financing optionality and market access.

For a concise review of Zhongchao’s supplier and external relationships and how they affect counterparty risk and financing strategy, visit https://nullexposure.com/.

Where the business stands today — financial signals that matter to counterparties

Zhongchao reports TTM revenue of $13.12M and gross profit of $6.88M, but profitability is negative with diluted EPS of -$1.52 and operating margin roughly -15.7%. Market capitalization is approximately $6.9M, shares outstanding are limited (≈3.2M), and insider ownership is meaningful at ~26%, while institutional ownership is negligible at 0.33%. Price-to-sales (~0.53) and price-to-book (~0.34) reflect depressed market valuation relative to book and sales. These numbers underline a company that generates revenue but requires ongoing capital access to restore positive earnings and scale margins.

Supplier and capital-market relationships you need to map

Below I list every relationship captured in the public record for ZCMD and summarize the commercial or market role of each counterparty.

Network 1 Financial Securities, Inc.

Network 1 acted as lead underwriter and bookrunner for a Zhongchao offering in FY2020, which situates the firm as a past capital markets intermediary for the company. According to China Daily coverage from February 2020, Network 1 filled the underwriting role for that transaction (https://www.chinadaily.com.cn/a/202002/23/WS5e51bdcaa31012821727989f.html).
Takeaway: underwriting history signals a precedent for market access through U.S.-facing boutique underwriters.

Nasdaq Stock Market

Zhongchao is listed on the Nasdaq Stock Market, which imposes listing and compliance obligations that shape public reporting cadence and governance; Nasdaq’s regulatory framework has been invoked in coverage of a FY2025 compliance matter. A press item discussing Nasdaq-related compliance for Zhongchao appeared on The Globe and Mail in FY2025 (https://www.theglobeandmail.com/investing/markets/stocks/ZCMD-Q/pressreleases/36407847/zhongchao-inc-faces-nasdaq-compliance-challenge/).
Takeaway: public listing on Nasdaq creates both market-disclosure discipline and potential regulatory pressure that affects financing windows.

Weitian Group LLC

Weitian Group LLC surfaces as an investor-relations contact referenced in a FY2024 issuance about corporate actions; the link lists Sherry Zheng at Weitian as the IR point of contact, indicating Weitian’s role in shareholder and investor communications (digitalmore.co FY2024: https://digitalmore.co/zhongchao-inc-announces-1-for-10-share-consolidation/).
Takeaway: Weitian functions as a direct conduit to investors and suggests outsourced IR support for U.S. or global audiences.

WAVECREST GROUP INC.

WAVECREST Group Inc. is listed in FY2026 investor-relations material as another IR/administrative contact (news.futunn.com FY2026: https://news.futunn.com/en/post/69299983/zhongchao-inc-announces-1-for-8-share-consolidation). The listing repeats the Sherry Zheng contact and a +1 phone number, reflecting a continuity of external IR channels.
Takeaway: multiple named IR agents suggest the company maintains overlapping channels for investor outreach and corporate actions execution.

What the relationship map implies about Zhongchao’s operating model

The visible relationships combine capital markets intermediaries, the listing venue and outsourced investor-relations contacts. From a company-level signal perspective (no explicit contractual constraints disclosed in source materials), these elements point to several operational characteristics:

  • Contracting posture: Zhongchao leverages external capital-market partners for financing and outsourced IR for market communications, indicating a lean internal capital-marketing function and reliance on third parties for public company mechanics. This posture reduces fixed overhead but increases dependency on external counterparties for market access and reputation management.

  • Concentration: The small free float and elevated insider ownership combined with a narrow set of named external partners imply concentrated counterparty exposure in capital-market and IR services rather than a diversified supplier base.

  • Criticality: Underwriters, the exchange, and IR vendors are highly critical to Zhongchao’s ability to raise capital, meet compliance obligations, and maintain liquidity in public markets; disruption to any of these relationships would meaningfully impair financing and investor communication.

  • Maturity: Relationship tenor shows a mix of historical underwriting (FY2020) and more recent IR contacts (FY2024–FY2026), suggesting evolving maturity: prior capital raises were completed, more recent activity centers on corporate actions and compliance.

Because no explicit contractual constraints were extracted from the sourced materials, the company-level signal is that external constraint reporting is limited in the public record, which raises the informational premium for counterparties conducting diligence.

Investment implications — where to focus diligence

  • Liquidity and refinancing risk are primary. With negative earnings and a sub-$7M market cap, Zhongchao depends on periodic capital raises; past underwriting and IR relationships make such raises operationally feasible but not guaranteed.
  • Regulatory and listing risk is elevated. Nasdaq compliance actions referenced in FY2025 amplify the cost of non-compliance and heighten disclosure scrutiny.
  • Counterparty dependency is concentrated. A small set of named external partners for underwriting and IR increases execution risk if any vendor relationship degrades.
  • Operational scale constraint. Revenue generation exists, but margins and EPS trends show the company is not yet at a scale that insulates it from financing cycles.

If you are evaluating a supplier relationship or considering exposure to Zhongchao’s financing, prioritize confirmation of current underwriting arrangements, the status of Nasdaq compliance items, and the continuity of investor-relations support.

For a concise monitoring toolkit and mapping of supplier exposures, review resources at https://nullexposure.com/.

Actionable next steps for operators and investors

  • Validate the current underwriting capability and any standby financing commitments with direct counterparties.
  • Confirm the company’s current Nasdaq compliance status and any remediation timelines to assess short-term liquidity windows.
  • Audit IR contracts and vendor redundancy to determine single-point-of-failure risk in investor communications.

To explore counterparty risk matrices and live supplier mapping, see https://nullexposure.com/.

Bottom line

Zhongchao is a revenue-generating health-information and training company listed on Nasdaq but operating with negative profitability, limited market cap, and concentrated external dependencies. The explicit relationships with an underwriter (Network 1), exchange oversight (Nasdaq), and external IR providers (Weitian; WAVECREST) create the operational infrastructure for financing and public-market engagement, yet they also concentrate execution risk. Investors and operators should prioritize confirming the durability of those links and the company’s standing with Nasdaq before underwriting additional exposure.